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A RAB35-p85/PI3K axis controls oscillatory apical
protrusions required for efﬁcient chemotactic
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How cells move chemotactically remains a major unmet challenge in cell biology. Emerging
evidence indicates that for interpreting noisy, shallow gradients of soluble cues a system
must behave as an excitable process. Here, through an RNAi-based, high-content screening
approach, we identify RAB35 as necessary for the formation of growth factors (GFs)-induced
waves of circular dorsal rufﬂes (CDRs), apically restricted actin-rich migratory protrusions.
RAB35 is sufﬁcient to induce recurrent and polarized CDRs that travel as propagating waves,
thus behaving as an excitable system that can be biased to control cell steering. Consistently,
RAB35 is essential for promoting directed chemotactic migration and chemoinvasion of
various cells in response to gradients of motogenic GFs. Molecularly, RAB35 does so by
directly regulating the activity of p85/PI3K polarity axis. We propose that RAB35 is a
molecular determinant for the control of an excitable, oscillatory system that acts as
a steering wheel for GF-mediated chemotaxis and chemoinvasion.
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Cells and particularly tumour cells use different motilitymodes to disseminate1. Each of these modes is driven andcontrolled by distinct molecular pathways, the nature of
which remains largely unexplored. In one such strategy, referred
to as mesenchymal motility, single cells may detach from the
tumour mass and advance as individual, invasive units2. One of
the ﬁrst steps of mesenchymal migration and invasion, particu-
larly in response to growth factors stimulation, is the acquisition
of a front-to-back polarity, which is driven by the extension of
different kind of actin-based migratory protrusions, including
canonical actin-rich ﬂat lamellipodia, small ﬁnger-like ﬁlopo-
dia3,4, sausage-like lobopodia5, blebs6 and the poorly studied,
apically localized circular dorsal rufﬂes (CDRs)7. CDRs have been
proposed to be markers of cellular transition from amoeboid to
mesenchymal migration8. Topologically, CDRs are formed on the
dorsal surfaces of the cells. They often initiate in a polarized spot
on the membrane, from which they ﬁrst expand as a ring7,9, to
subsequently contract centripetally, generating a cup-like struc-
ture, leading to the formation of macropinosomes10. Consistently,
these structures are sites of growth factor-induced macro-
pinocytic internalization and promote the endocytosis of various
membrane-bound molecules including epidermal growth factor
(EGF)11 and non-ligand engaged β3 integrin12.
Among the growth factors known to elicit robust and direc-
tional migration, hepatocyte growth factor (HGF) in epithelial
cells13 and platelet-derived growth factor (PDGF)14,15 in ﬁbro-
blasts, have been shown to be potent and speciﬁc inducer of
CDRs7. Molecularly, the formation of CDRs requires the activa-
tion of the respective cognate receptor tyrosine kinases, PDGFR
and c-MET, which in turn trigger the recruitment of signalling
complexes that invariably lead to the modulation of the actin
polymerization7,9. A pivotal role, in this context, is exerted by
RAC1 (ref. 16), whose activity must become spatially restricted for
CDRs to form8,17–19. Additional important factors in the for-
mation of CDRs are lipid kinases, and speciﬁcally PI3K as both
pharmacologically or genetic inhibition of this enzyme abrogate
their formation by preventing the generation of phosphatidyli-
nositol-3,4,5-phosphates important for the recruitment of mem-
brane binding, curvature sensitive Bin-Amphiphysin-Rvs (BAR)-
containing proteins16 as well as to activate RAC1 GEFs, including
TIAM1 (refs. 8,17) and DOCK1 (ref. 20). Notably, the latter pro-
tein has recently been shown to mediate CDRs formation acting
speciﬁcally downstream of oncogenic forms of KRAS20. Activated
RAS molecules have, indeed, long been shown to promote CDRs
and macropinocytosis21,22, which is exploited as a mean to sca-
venge protein and lipid sources in order to reﬁll the amino acid
pools, fuel mitochondrial metabolism and lipid biosynthesis23–26,
ultimately fostering survival in nutrient-deprived, tumour
microenvironment. Thus, CDRs are emerging as structures that
integrate migratory and endocytic processes, and as such can be
exploited by certain tumours to enhance their metabolic plasticity
and invasiveness. The identiﬁcation of key molecular determi-
nants governing their formation is, therefore, paramount and
likely to have important implications for our understanding of
how cells perceive, respond and adapt to soluble environmental
cues.
One striking feature of CDRs, in addition to their distinct
circular architecture, is their peculiar kinematic behaviour. CDRs
are transient, forming only once upon stimulation7,10, and fre-
quently form in a recurrent wave-like pattern10. In addition, they
display a polarized distribution, particularly when induced by
local gradients of growth factor10. These combined kinematic
properties suggest that these structures may operate as an oscil-
lating device or steering wheel in driving chemotactic motility. It
follows that factors controlling their formation might be critical
chemotactic sensor or regulator and promoter of a directional,
mesenchymal mode of motility by speciﬁcally controlling growth
factor-mediated cell steering.
Here, by exploiting CDRs as an easy-to-follow read out for an
automated high-content, imaging-based screening, we identify
RAB35 as necessary and sufﬁcient for CDR formation. We fur-
ther show that RAB35-induced CDRs behave as recurrent and
propagating waves. Addition of growth factor induces their
polarized formation, suggesting that these structures are indeed
actin-based oscillatory systems that might be biased for efﬁcient
chemotaxis. Accordingly, RAB35 is involved in efﬁcient chemo-
taxis in various migratory systems. Molecularly, RAB35 acts
downstream of RAB5A/RAC1 pathways by directly binding and
controlling the activity of p85α, the regulatory subunit of PI3K.
Collectively, our ﬁndings uncover a pivotal role of RAB35/
p85–PI3K axis in controlling oscillatory CDR protrusions for
efﬁcient chemotaxis and macropinocytosis.
Results
RAB35 is essential for CDRs formation. We used CDRs as a
read out for an RNAi-based phenotypic screening to identify new
critical players promoting their formation and set out to test
whether they are acting as oscillating waves steering cells during
chemotaxis.
Given the involvement of CDRs in endocytic processes12,13, we
speciﬁcally targeted each of the mammalian members of the RAB
GTPase family, which includes more than 60 independent
genes27. RAB GTPases, by controlling key steps of endocytosis
and vesicular trafﬁcking, are necessary for the execution of actin-
based polarized functions that are in turn essential for cell
migration and invasion27. We devised a multistep screening
strategy. For the primary screening, we used mouse embryonic
ﬁbroblasts (MEFs) as model system because in response to PDGF
stimulation the large majority of cells form easily detectable and
prominent CDRs that appear in a highly synchronous, temporal
fashion (with a peak after 10 min of stimulation). We employed a
custom siRNA library, targeting all the members of the family
(about 60 genes using three individual siRNAs for each gene,
Supplementary Data 1), arrayed onto 96-wells imaging plates. We
developed a ﬂuorescence-based imaging pipeline to automatically
monitor and quantitatively score the formation of CDR in PDGF-
stimulated MEFs (for details see Methods and Supplementary
Figure 1A–C). The accuracy of our pipeline was evaluated by
manually/visually inspecting a subset of randomly chosen images
in order to measure the ability to correctly recognize CDRs. The
true-positive and false-positive rate of CDR recognition were 0.94
and 0.23, respectively. Raw data were quality controlled by
removing images with a low number of nuclei (in all these cases
the corresponding siRNA was considered as inconclusive/
cytotoxic) and by discarding out-of focus images. In addition,
we systematically evaluated plates based on the transfection
efﬁciency of our cells (~80 %) that was measured by counting the
percentage of polylobed nuclei upon Incenp downregulation
(Supplementary Figure 1C). Finally, the efﬁciency in forming
CDRs was normalized in each experimental condition with
respect to the negative control (siEGFP) of the screening
(Methods) to obtain a CDR score that was used to rank the
various treatments (Fig. 1a). The top regulator of CDRs included,
as expected, the β isoform of the PDGF receptor, and few RAB
GTPases, among which RAB35, the silencing of which resulted in
one of the most robust inhibition of CDRs formation (Fig. 1a and
Supplementary Data 2). Next, we performed an independent
secondary validation step by focusing on those genes for which at
least two out of three siRNAs resulted in a CDR score <0.4
(Supplementary Data 2). Gene silencing in these cases was
veriﬁed by quantitative RTPCR analysis (Fig. 1b). The silencing of
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RAB35, RAB8A and RAB8B resulted in a robust and reproducible
decreased in CDR activity, thus corroborating the validity of the
primary screen and providing evidence that RAB35 is the main
regulator of CDR formation among the mammalian RAB protein
family (Fig. 1b).
To prove that the CDR-phenotype associated with
RAB35 silencing is the result of speciﬁc targeting of the gene
and rule out off-target effects, we performed a rescue experiment.
To this end, we generated a population of MEF cells expressing
the HA-tagged human form of RAB35, which is resistant to the
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Fig. 1 siRNA screening for RAB GTPases involved in CDRs formation. a siRNAs targeting RAB GTPases were ranked according to their CDR score (Methods
and Supplementary Figure 1). Representative images of positive (siPdgfrb) and negative (siEGFP) controls are, respectively, in red and green. siRNAs best
inhibiting CDR formation (more than 60% reduction relative to scrambled siEGFP) are enclosed into the light grey box. The oligo s95003 targeting Rab35,
indicated in blue, is reported as a representative example. Red arrows indicate CDRs. Scale bar, 50 μm. b The siRNAs that inhibited CDRs formation more
efﬁciently were validated in a completely independent experiment. Left: MEF cells interfered for Rab35 (ID: s95002, s95003), or Rab8a (ID: s69778,
s69779), or Rab8b (ID: s108154, s108155, s108156), Pdgfrb (positive control), or Scrambled oligo (negative control). Upon PDGF stimulation, cells were
ﬁxed and stained with phalloidin. Representative images are shown for each experimental condition. Red arrows indicate CDRs. Scale bar, 50 µm. Right:
CDRs were manually counted and normalized against scrambled-transfected, control samples. Data are the mean ± SD (n > 200 cells/condition in three
independent experiments). The silencing of the targeted genes was veriﬁed by qRTPCR
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murine oligo used to induce the silencing of the endogenous gene
product, in a doxycycline-inducible fashion. Cells interfered for
endogenous RAB35 displayed reduced CDR formation, which
was fully rescued by the expression of the human protein
(Fig. 2a). Of note, ectopically expressed RAB35 was diffuse on the
cytoplasm and present on the plasma membrane, but re-localized
to CDRs following stimulation with PDGF (Supplementary
Figure 1D).
In addition to be migratory, CDRs are also sites of
macropinocytic internalization28. Real-time phase contrast
microscopy, consistently, revealed the formation of large ﬂuid-
ﬁlled, vesicle-like structures that invariably form following CDR
closure (Supplementary Movie 1). This was mirrored by PDGF-
mediated increase in the internalization of large molecular weight,
ﬂuorescently labelled Dextran, a bona ﬁde macropinocytosis
cargo. Importantly, MEFs stably downregulated for RAB35 were
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severely impaired in the internalization of dextran (Fig. 2b),
reinforcing the notion that this GTPase is critical for CDRs
formation and their endocytic functional activity.
We further validated our ﬁnding in a different cellular context.
We used HeLa cells, which are of epithelial origin and form CDRs
in response to HGF stimulation29. Silencing of RAB35 in these
cells severely decreased CDRs formation as compared to
scrambled-transfected cells (Supplementary Figure 1E), indicating
that RAB35 is a critical regulator of CDR formation in response
to different growth factor-dependent signalling pathways.
Finally, to establish whether RAB35 is also sufﬁcient to induce
these structures, we monitored by time-lapse phase contrast
microscopy MEF cells expressing HA-RAB35 in a doxycycline-
inducible fashion cultured in growing media without any addition
of growth factors. Importantly, up-regulation of RAB35 was
sufﬁcient to promote the formation of multiple CDRs that display
a persistent and rapid dynamics, as conﬁrmed by the quantiﬁca-
tion of the number of events per cell monitored in 1 h (Fig. 2c and
Supplementary Movie 2). This was mirrored by an increased rate
of ﬂuorescently labelled dextran internalization (Fig. 2d)
Collectively, these ﬁndings identify RAB35 as a non-previously
characterized RAB GTPase essential for the formation of CDRs in
response to stimulation with various growth factors.
RAB35-controlled CDRs act as cell steering devices. CDRs play
a key role in cytoskeleton remodelling associated with the tran-
sition from sessile to motile states7. In addition they frequently, if
not invariably, form in close proximity to the cell leading edge30,
and are capable of initiating endo/exocytic cycles of plasma
membranes and integrins that are subsequently delivered in a
polarized fashion to the prospective lamellipodia11,12,31,32. These
properties suggest that CDRs may function as bona ﬁde cellular
steering compasses to initiate forward and directional chemo-
tactic migration. Given the relationship between CDRs, cell
locomotion and cell guidance, we further hypothesize that RAB35
by controlling their formation may also be essential for regulating
directional, chemotactic motility.
To act as steering devices CDRs must form in a polarized
fashion in response to local gradient of chemotactic growth
factors, and their dynamics formation should be spatiotemporally
correlated with the extension of lamellipodia protrusions. In
addition, structural components and biochemical wiring involved
in cell migration guidance are often behaving as excitable
oscillatory systems, which may become spatiotemporally biased
following chemoattractant exposure33. The propagation of actin
waves at the ventral surface of neutrophil is a typical case in
point34–37. We veriﬁed whether CDRs display all these features.
Firstly, we monitored by time-lapse microscopy their formation
and recorded the subsequent extension of lamellipodia in
response to local delivery of PDGF. CDRs formed in polarized
directions and their appearance/disappearance was followed by
the subsequent extension of ﬂat lamellipodia-like protrusions
following the local delivery of PDGF (Fig. 3a and Supplementary
Movie 3). The temporal correlation between CDR and leading-
edge protrusions was robust in RAB35-expressing cells. RAB35-
expressing, but not control cells, form multiple CDRs in the
absence of any added growth factor and these structures precede
the extension of lamellipodia with a lag phase of about 105″
(Fig. 3b and Supplementary Movie 4). We further exploited the
ability of RAB35 to induce a constitutive wave of recurrent
multiple CDRs to characterize their overall dynamics and
kinematics in more details and relate it to the extension of
membrane protrusions. We observed travelling CDR waves,
where CDR formed at the rear of an elongated, spatially restricted
pseudopodia-like protrusion and move persistently along and in
synchrony with the extended protrusion, with nearly identical
speed (Fig. 3c and Supplementary Movie 5). We further detected
multiple CDRs expanding centrifugally, behaving as iterative
waves that form in diverse, but generally peripheral positions
expanding centrifugally toward the cell edge (see Supplementary
Movies 4). Finally, we detected recurrent and oscillating CDRs
waves, which form repeatedly in the same location expanded and
enclosed with a typical oscillatory frequency of about 20 min
(Fig. 3d and Supplementary Movie 6). Collectively, these features
support the notion that CDRs behave as an excitable system of
propagating waves, which can be biased by exogenously added
PDGF to promote cell steering and chemotactic motility33.
If CDRs are indeed bona ﬁde, excitable, steering devices, their
perturbation should impair directional motility, particularly
toward growth factors known to induce robustly their formation
right at the onset of chemotaxis. To this end, we ﬁrst measured
the ability of MEFs to migrate through a microporous membrane
towards a PDGF gradient in a Boyden chamber assay. Scrambled
and RAB35-silenced cells (we used three independent siRNAs)
were seeded into Transwell chambers. After 20 h, cells on the top
of the membrane were scraped away and the ones migrated at the
bottom were stained with crystal violet. An additional time point
was taken 3 h after cell plating to demonstrate that we seeded an
equal number of cells, which display similar adhesion efﬁciency
across all the different experimental conditions. The loss of
RAB35 signiﬁcantly and robustly reduced the number of cells
crossing the porous ﬁlter by chemotaxis (Fig. 4a). To monitor
MEF chemotaxis in real time and to explore the potential
Fig. 2 RAB35 impairs CDRs formation. a An siRNA-resistant human RAB35 rescues CDRs formation. Doxycycline-treated pSLIK-HA-RAB35-human
infected MEFs silenced for endogenous RAB35 were serum starved for 2 h, and stimulated with PDGF for 10′. Samples were co-stained with FITC-
Phalloidin and the anti-HA antibody to detect F-actin and human HA-RAB35, respectively. Red arrows indicate CDRs. Scale bar, 50 µm. CDR score was
calculated by normalizing the number of CDR-positive cells per each condition against the scrambled doxycycline-untreated, PDGF-stimulated sample,
used as a control. Data are the mean ± SD (n > 100 cells/condition, three independent experiments). The silencing of endogenous RAB35 was veriﬁed by
qRTPCR. b Silencing of RAB35 impairs macropinocytosis. MEF control (shCtrl) and Rab35-downregulated (shRab35) cells were serum starved for 2 h and
incubated (+) or not (−) for 1 h with PDGF and tetramethylrhodamine-dextran. Upon ﬁxation, cells were processed for epiﬂuorescence to identify nuclei
(blue) and TMR-dextran-positive macropinosomes (red), respectively. Scale bar, 20 µm. Bottom graph, dextran uptake was quantiﬁed by determining the
total cell ﬂuorescence/cell (see Methods) expressed as A.U. Data are the mean ± SD (n= 40 cells/condition, three independent experiments). **p < 0.01;
*p < 0.05. The downregulation of RAB35 was veriﬁed by qRTPCR. c RAB35 is sufﬁcient to induce the spontaneous formation of CDRs. MEF control (Ctrl),
HA-RAB35-expressing (HA-RAB35) and Rab35-silenced (siRab35) cells were monitored for 1 h by time-lapse in the absence of PDGF. Still phase contrast
images from time-lapse sequence (Supplementary Movie 2) are shown. Red arrows indicate CDRs. Scale bar, 50 µm. The number of CDRs/cell formed in 1
h is expressed as mean ± SEM (n= 60 cells/condition, three independent experiments). ****p < 0.0001. RAB35 mRNA levels were determined by qRTPCR.
d RAB35 expression promotes macropinocytosis in the absence of GFs. Doxycycline-treated pSLIK-HA-RAB35-human-infected MEFs were incubated for 1
h with TMR-dextran. Cells were processed for epiﬂuorescence to visualize nuclei (blue), TMR-dextran-positive macropinosomes (red) and the ectopic
expression of HA-RAB35 protein (green). Quantiﬁcation of dextran uptake performed as in b. The total ﬂuorescence/cell was expressed as A.U. Scale bar,
20 µm. Data are the mean ± SD (n= 40 cells/condition, three independent experiments). *p < 0.05. p-values are from paired Student’s t-test
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underlying cellular alterations, we employ a microﬂuidic
commercial device that generate a stable linear gradient of
PDGF. We used the ImageJ plugin Chemotaxis tool to extract
migratory parameters, including forward migration index (che-
motaxis) and mean velocity. Silencing of RAB35 signiﬁcantly
impaired chemotaxis and reduced mean cell velocity (Fig. 4b and
Supplementary Movie 7).
To understand whether the altered migratory capability
observed upon RAB35 ablation is an intrinsic defect in the
molecular machinery sustaining cell locomotion, we also
monitored the migratory behaviour of sparsely seeded Ctrl and
short hairpin-silenced RAB35 cells in the absence of any external
guiding factor in a random migration assay. Under these
conditions, we found that RAB35 loss caused a signiﬁcant but
marginal decrease in cell velocity and had no effect on the
formation of lamellipodia protrusions, suggesting that the
machinery generating locomotory forces was not strictly
dependent on RAB35 (Fig. 4c and Supplementary Movie 8). On
the contrary, the stable up-regulation of RAB35, which promoted
that extension of multiple and subsequent waves of CDRs,
signiﬁcantly reduced persistent motility (indicated as direction-
ality) and altered mean velocity (Fig. 4c). These latter observa-
tions are consistent with the possibility that multiple and short-
lived CDRs are induced by the expression of the transgene,
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leading to cells that frequently change the direction of their
protrusions and motion, and cannot persistently move in a biased
direction. To further substantiate this notion, we analysed the
migratory behaviour of control and RAB35-silenced MEFs
moving along a PDGF gradient through an array of pillars where
directional decision choices must be made. The array is composed
of pillars from a photocurable hybrid polymer separated by a 4-
μm space (Fig. 4d). Control cells navigate toward the PDGF
gradient by extending persistent migratory protrusions, most of
which were oriented coherently with the direction of the gradient.
Conversely, loss of RAB35 reduces signiﬁcantly chemotaxis and
the number of cells with protrusions oriented along the gradient
(Fig. 4d).
Finally, if our model were correct, we would expect that RAB35
loss might not be strictly required for migration toward stimuli
that poorly or do not induce CDRs formation. Consistently, we
showed that RAB35 loss inhibited chemotaxis of MEFs toward
serum, which poorly induces CDR formation, much less
drastically than toward PDGF (Fig. 5a, b). Additionally, RAB35
was dispensable for chemotactic migration toward EGF, which is
unable to induce the formation of CDRs in MEFs (Fig. 5c, d).
Similarly, RAB35 loss had no effect on MEFs migration in scratch
wound assays. Under these latter conditions, cells migrate by
kenotaxis without forming CDRs, while extending lamellipodia
and ﬁlopodia protrusions like control cells (Fig. 5e and
Supplementary Movie 9).
RAB35 is required for chemoinvasion. Collectively, our ﬁndings
argue that deﬁciency in CDR formation leads to a slight
impairment in cell locomotion but a more dramatic inhibition of
directional sensing and chemotactic-guided migration further
impacting on cell persistence, at least during crawling locomotion
on two-dimensional (2D) surfaces typically measured by all these
assays. In vivo, however, cell migration occurs within complex
three-dimensional (3D) matrices with different structural orga-
nization, ﬁbres composition and physical properties. Under these
conditions, cells frequently move along single ECM ﬁbres or
narrow channels that impose a deﬁned, physical conﬁnement. To
this end, we performed migratory assays on one-dimensional
(1D) micro-printed as well as suspended ECM lines. These assays
mimic 1D tumour interstitial migration and allow, through the
live monitoring of cell motion, a precise control of migratory
parameters. Using suspended ﬁbres, we showed that RAB35
ablation impeded the crawling mode of locomotion. Cells devoid
of RAB35 were no longer able to extend trains of expanding wave
and were stuck on the ﬁbres (Supplementary Movie 10). Next, to
provide a more reliable quantitation of this phenotype, we turned
to 1D micro-printed ﬁbronectin tracks. We seeded MEF shCtrl
and shRAB35 cells on lines of 10 μm in width and monitored
their 1D locomotion by time-lapse phase contrast microscopy for
24 h. Cell trajectories were automatically reconstructed by a build
in-house ImageJ macro and a number of migratory parameters
were extrapolated. Results showed that the absence of RAB35
affected cell velocity, the total length covered and, more rele-
vantly, the persistence of cell motion (Fig. 6a and Supplementary
Movie 11).
Next, we wondered whether this protein might also play an
active role in tumour cell dissemination in 3D matrix. To address
this point, we tested MCF10.DCIS.com cells stably downregulated
for RAB35 in a set of in vitro migratory/invasive assays. This cell
line is an oncogenic variant of MCF-10A that is widely used to
recapitulate the transition from an in situ ductal to an invasive
breast carcinoma38,39. We ﬁrst measured the ability of RAB35-
depleted cells in migrating through a microporous membrane
towards an HGF gradient in a Boyden chamber assay. Ablation of
RAB35 profoundly affected the chemotactic migratory ability of
MCF10.DCIS.com cells (Fig. 6b). In addition, we also observed
that control cells displayed a higher ability to invade and migrate
through a thin layer of Matrigel in comparison to RAB35-
downregulated cells, as shown in the Matrigel invasion assay
(Fig. 6c). To further validate this ﬁndings, we monitored by time-
lapse phase contrast microscopy the invasive migration of control
and RAB35-depleted MCF10.DCIS.com cells into 3D gels of
native type I collagen enriched with the motogenic factors
HGF40–42. Control cells readily invaded the 3D matrix.
Conversely the chemoinvasive potential of RAB35-deﬁcient cells
was impaired as demonstrated by the reduced invasive forward
index and cell velocity (Fig. 6d and Supplementary Movie 12).
Finally, we exploited the ability of MCF10.DCIS.com cells to
generate invasive outgrowths in 3D basement membrane43.
Control and RAB35-silenced MCF10.DCIS.com cells were seeded
as single cells onto a gel composed of Matrigel and type I collagen
and allowed to form spheroids. The addition of HGF in the
presence of collagen type I is known to trigger an invasive
programme, characterized by the outgrowths of multicellular
structures that expand from the regular contour of the
spheroids44. This transition recapitulates what seen in vivo when
in situ ductal carcinoma, conﬁned into the lumen of a duct,
convert into invasive ductal carcinoma through the extension of
local multicellular protrusions44. The percentage of acinar
structures that form invasive outgrowths was signiﬁcantly
reduced in RAB35-depleted cells (Fig. 6e), reinforcing the notion
that RAB35 is necessary to promote a mesenchymal programme
of chemotactic cell invasion in vitro.
Fig. 3 Kinematics of CDRs. a CDRs formation anticipates protrusion extension with a typical lag phase. Top: Still images from a representative time-lapse
(Supplementary Movie 3) of MEFs stimulated by PDGF delivered with a micropipette. Grey arrow indicates the position of released PDGF; red and white
arrows indicate CDR and protrusions extension, respectively. The white dashed line indicates the ROI used to perform the kymograph (bottom right panel).
Scale bar, 20 µm. Bottom left: Cartoon depicting the dynamics of CDRs and protrusions. Bottom right: kymograph of leading-edge dynamics. T0 PDGF
stimulation time, T1 CDR closure time, T2 protrusion extension times. b RAB35 promotes the formation of multiple CDRs that expand centrifugally and
precede the extension of leading-edge protrusions. Top: pSLIK-HA-RAB35-human-MEFs were infected with EGFP-LifeAct and treated or not with
doxycycline to induce transgene expression. Samples were monitored by time-lapse every 30″ for 60′ (Supplementary Movie 4) and still images are
shown. Scale bar, 50 µm. Boxes indicate magniﬁed areas shown on the side (Scale bar, 20 µm). Red and white arrows indicate CDRs and protrusion edge,
respectively. Bottom left: the lag phase between CDR closure and the subsequent protrusion extension is expressed as mean ± SD (n= 30 cells/
experiments, three independent experiments). Bottom right: RAB35 expression was veriﬁed by imunoblotting. c Travelling CDR waves induced by RAB35.
Top: pSLIK-HA-RAB35-human-MEFs were infected with EGFP-LifeAct and treated or not with doxycycline to induce transgene expression. Samples were
monitored by time-lapse every 30″ for 20′. Still images from time-lapse sequence (Supplementary Movie 5). Scale bar, 50 µm. The dashed line indicates
the ROI used to perform the kymograph. Middle: Kymograph of cell edge (blue) and CDR (red). Bottom: The propagation speed of CDR (red) and leading-
edge protrusions (blue) induced by RAB35 is expressed as mean ± SD (n= 30 cells, three independent experiments). d Oscillating CDR waves induced by
RAB35. Doxycycline-treated pSLIK-HA-RAB35-human-EGFP-LifeAct-expressing MEFs were imaged every 30” for 1 h period. Still ﬂuorescence images from
time-lapse sequence (Supplementary Movie 6). Red arrows point the recurrent CDR formation. Scale bar, 10 µm. A representative frequency of recurrent
waves. Red arrows indicate peaks that correspond to CDRs
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A RAB35–p85–PI3K axis mediates chemotactic responses to
PDGF. What are the cellular processes and molecular pathways
RAB35 uses to promote CDR and steer cells in response to
chemotactic stimuli?
To address this question, we initially turned to the well-
established functional role of RAB35 in controlling clathrin-
dependent endocytic internalization and membrane trafﬁcking.
More speciﬁcally, we tested the possibility that manipulation of
RAB35 levels would impact on the trafﬁcking of growth factor
receptors, focusing on PDGFRB. However, no difference in either
total PDGFRB or surface amounts could be found following
silencing (Supplementary Figure 2A) or ectopic up-regulation
(Supplementary Figure 2B) of RAB35.
We next utilized a molecular epistasis approach to position
RAB35 action on known pathways controlling CDRs7. We have
previously shown that the formation of these structures requires
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an active PDGFR, which function as a ﬁrst-line sensor and a
transducer of PDGF signalling, and a functional endosomal
trafﬁcking route, in turn, necessary to spatially restrict RAC1-
activity and RAC1-dependent actin remodelling into CDR8,
deﬁning an epistatic relationship between these components
(Fig. 7a). To position RAB35 along this pathway, we exploited the
ﬁnding that elevation of the levels of this protein is sufﬁcient to
promote multiple CDRs in the absence of GF. Speciﬁcally, we
monitored by time-lapse phase contrast microscopy the dynamics
of CDRs in MEF cells silenced for Pdgfrb, or Rab5a, band c or
Rac1 in control (−DOX) and doxycycline-inducible, RAB35-
expressing populations (+DOX). The number and dynamics of
CDR formation, as expected, was robustly increased upon
elevation of RAB35 levels. The silencing of PDGF receptor had
no effects on CDR, consistently with the notion that elevation of
RAB35 is sufﬁcient to bypass the need of ectopic addition of
growth factor to induce these protrusions. On the contrary,
silencing of Rab5 or Rac1 genes nearly completely abrogated
RAB35-induced CDRs (Fig. 7b and Supplementary Movie 13).
Thus, RAB35 appears to act downstream of PGDF receptor and
either upstream or in a parallel RAB5/RAC1 pathway.
To investigate further this latter possibility and gain a
molecular understanding of the mechanisms of action of
RAB35, we systematically silenced all, the so far-identiﬁed,
molecular effectors (Ocrl, Rusc2, Acap2, Mical1, Micall1, Fscn1
and p85) as well as guanine nucleotide exchange factors
(Dennd1a, Dennd1b, Dennd6b and Flc) of this GTPase45,46.
MEF cells were systematically downregulated for the indicated
genes [only in the case of p85 we used MEFs double KO of the
two isoforms p8547 instead of performing the transient down-
regulation of the genes], serum starved for 2 h, stimulated with
PDGF and scored for the ability to form CDRs. The resulting
CDR score showed that the genetic ablation of p85 isoforms was
the sole manipulation able to phenocopy the loss of RAB35
(Fig. 7c). The lack of effects of critical downstream effectors
mediating RAB35 known role as modulator of endocytosis
further strengthened the notion that this function may not be the
one used to control CDR formation.
To provide evidence of a direct causal link between p85/PI3K
axis and RAB35, we performed three sets of experiments. Firstly,
we inhibited PI3K activity, which strictly depends on its
association with the regulatory subunit p85α and p85β, using a
pharmacological inhibitor. Treatment of PDGF-stimulated with
LY294002 or the more speciﬁc GDC-0941 PI3K inhibitors, the
efﬁcacy of which was tested by measuring the phosphorylation
levels of the PI3K target and effector protein AKT, severely
abrogated the formation of CDRs (Supplementary Figure 3A–B).
Inhibition of AKT with MK-2206 had, instead, no effect on
PDGF-induced CDRs formation nor on macropinocytosis
(Supplementary Figure 3C). More importantly, pharmacological
inhibition of PI3K also effectively abrogated CDRs induced by the
sole expression of RAB35 (i.e. in the absence of PDGF addition)
(Fig. 8a and Supplementary Movie 14). We corroborated the
latter ﬁndings using MEF-KO for p85α and β. These cells and the
related control cells were engineered to express RAB35 in a
doxycycline-inducible fashion and monitored by time-lapse phase
contrast microscopy. Removal of p85α and β completely
prevented the formation of highly dynamic CDRs induced by
RAB35 expression (Fig. 8b and Supplementary Movie 15). Finally,
we tested biochemically whether RAB35 acts by directly
modulating p85/PI3K activity. Indeed, while we were working
on this project, RAB35 was identiﬁed as a critical and direct
activator of the p85/PI3K–AKT pathway, shown to directly
interact with the regulatory p85α subunit and to mediate, through
this pathway, cell transformation48. In agreement with this latter
ﬁnding, we found that silencing of RAB35 reduced signiﬁcantly
the phosphorylation of AKT in response to PDGF stimulation,
without affecting PDGFR phosphorylation status, and PDGFR-
dependent MAPK activity (Fig. 8c). We also showed that the
ectopic expression of RAB35, in doxycycline-stimulated MEF
pSLIK-HA-RAB35 cells cultured in growing conditions without
addition of growth factors, caused the hyper-activation of AKT
signalling without affecting the phosphorylation levels of other
transducers (Fig. 8d). Finally, RAB35 and p85α co-
immunoprecipitated. This interaction was enhanced upon growth
factors stimulation. Importantly, wild-type RAB35, but not an
inactive dominant-negative RAB35S22N mutant, associated with
endogenous p85α, whereas dominant active RAB35 interacted
with p85α in a constitutive growth factors-independent fashion
(Fig. 8e, f). These latter ﬁndings imply that stimulation with
growth factors might increase RAB35-GTP levels, leading to the
activation of p85/PI3K pathway. Consistent, with this notion a
dominant-negative RAB35S22N mutant abrogated PDGF-
induced CDRs formation and directional migration (Supplemen-
tary Figure 3D), whereas two recently identiﬁed activated,
tumour-associated RAB35 mutants, RAB35A151T and F161L48,
promoted CDRs formation and elevated AKT phosphorylation in
the absence of growth factor stimulation (Supplementary
Figure 3E and Movie 16). In addition, there is a correlation
between the levels of RAB35 and of phosphoAKT in prostate
cancer cell lines (Supplementary Figure 4A-B). Of note, the
analysis of the TCGA data set indicated that RAB35 display a
signiﬁcant elevated copy number variation in about 16% of
human prostate cancers (Supplementary Figure 4C). The variable
expression of RAB35 was also observed across a panel of human
prostate cancer in a Tissue Microarray (TMA) with 12/56 (21.4%)
adenocarcinoma displaying elevated levels of RAB35 (score ≥ 1.5),
whereas only 2/32 (6%) of normal prostate tissues displayed
Fig. 4 RAB35 is required for optimal directional motility and chemotaxis. a Transwell assays migration toward PDGF (20 ng/ml) of scrambled and Rab35-
silenced MEFs. Crystal violet staining was done after 3 h to detect total number of seeded cells, and after 20 h to detect migrated cells to the lower side.
The number of cells/ﬁeld on the lower side is the mean ± SD (>6 ﬁelds of view/condition). Gene silencing was veriﬁed by qRTPCR. Scale bar, 50 μm. b
Time-lapse of control (shCtrl) and Rab35-silenced (shRab35) MEFs moving toward PDGF (Supplementary Movie 7). Manually tracked cells were analysed
by Chemotaxis Tool ImageJ software plugin. Velocity and forward migration index are shown as whiskers box plots. Solid horizontal line=median value;
box outlines= 25th–75th percentiles; whiskers=min and max values. ****p < 0.0001. Silencing was veriﬁed by immunoblotting. c Time-lapse analysis of
sparsely seeded, control (shCtrl), Rab35-silenced (shRab35) and HA-RAB35-expressing (HA-RAB35) MEFs (Supplementary Movie 8). Cells were manually
tracked to calculate velocity and directionality (Euclidean distance/travelled distance). Mean ± SEM is reported in red (n > 40 cells/condition, three
independent experiments). ****p < 0.0001; **p < 0.01; *p < 0.05. d Chemotactic migration through an array of pillars of control (shCtrl) and Rab35-
downregulated (shRab35) MEFs. Left: scheme of the chemotactic device. An 4 µm inter-spaced micropillar array was inserted into a sticky-Slide
Chemotaxis chamber (Ibidi). Cells seeded in the cell pool area migrated over a PDGF chemotactic gradient. Cells motility was monitored by time-lapse.
Middle: still images of the time-lapse sequence. Superimposed red (shCtrl) and blue (shRab35) arrows indicate cell protrusion orientation. Scale bar, 50
µm. Top right: manually tracked cells were analysed by Chemotaxis Tool ImageJ software plugin. Forward migration index is reported as mean ± SEM.
Bottom right: the protrusion orientation angle (ϕ) of migrating cells, delimited by the protrusion extension and the direction of the PDGF gradient, was
calculated at different time point and is the mean ± SEM. Values of 0 and 90 indicate that protrusions are oriented along and parallel to the chemotactic
gradient, respectively (n > 100 cells/condition, three independent experiments). ***p < 0.001. p-values are from paired Student’s t-test
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RAB35 scores= 1.5 (Supplementary Figure 4D). These latter
results indicate that deregulation of the levels of this GTPase may
be positively selected in a subset of prostate tumours.
Discussion
How cells respond to chemotactic cues and more speciﬁcally how
they interpret relative shallow gradients frequently embedded in a
highly noisy environment is an issue that has long been fascinated
cell biologists. One emerging law in chemotaxis is that cells to
precisely guide their motion must make use of excitable, self-
oscillating systems33,49. Actin-based migratory protrusions that
randomly oscillate extending radially in crawling locomotory
cells50–52 or centrifugally expanding, ventrally restricted actin-
rich waves in neutrophil abide to this basic rule34,53. These
oscillating systems can, in addition, be biased to form in recurrent
and polarized fashion in response to chemotactic cues33,49.
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CDRs have also been proposed to displays similar fea-
tures7,31,54. Indeed, mathematical and biophysical models support
the notion that the growth and decay of CDR actin can be
explained as pulse propagation in an excitable media, in which a
wave is able to propagate in a nonlinear dynamical system, which
is the excitable media7,54. However, whether CDRs are linked to
chemotactic directional motility and the molecular determinant
driving their kinematics has remained, by and large, elusive. Here,
we provide evidence that the small RAB35 GTPase is necessary
and sufﬁcient to control the formation of CDRs and promote
their oscillating, recurrent dynamic behaviours (Fig. 9). We
showed that the elevation of RAB35 is sufﬁcient to induce the
formation of multiple CDRs that expand centrifugally, travel
along elongated protrusions, frequently in the form of oscillating
waves, that precede or accompany the extension of lamellipodia
protrusions. Stimulation with growth factors, including PDGF in
ﬁbroblast and HGF in epithelial cells, biased this behaviour, vir-
tually hijacking this excitable system for efﬁcient chemotactic
motility. Not surprisingly, RAB35 is essential for chemotaxis in
2D, directional locomotion in 1D and chemoinvasion in 3D in
various cellular systems.
Intriguingly, at the molecular levels, RAB35 controls the
activity of an extensively studied chemotactic p85/PI3K axis55
(Fig. 9). The absolute requirement of this axis in chemoguidance
remains somewhat controversial. Nevertheless, p85/PI3K signal-
ling node has been involved both in initiating as well as in biasing
and stabilizing branched protrusions, which have been proposed
to form stochastically, depending on cellular context55. In the case
of CDRs formation, the functional requirement of PI3K has long
been established56,57, and analysis of its activity and of coupled
lipid-phosphatases has revealed how this axis generate a complex
spatiotemporal dynamics of phosphatidylinositol-3,4,5-trispho-
sphate and its derivate products phosphatidylinositol 4,5-tri-
sphosphate precisely along the membrane conﬁning CDRs57,58.
This ﬁnding supports the notion that intrinsic PI3K-based feed-
back mechanisms control the duration, extent and the spatial
choreography of phospholipids, in turn necessary to modulate the
kinematics of CDRs. Within this context, RAB35, which naturally
cycles between inactive and active GTP, appears to be perfectly
suitable to act as a locally excitable GTPase that directly impinges
onto PI3K signalling network, ultimately tuning its activity in a
growth factors-dependent fashion. A corollary of this tenet is that
RAB35 should be locally accumulating in CDRs, as we showed,
and its activity might be spatially restricted at these sites. Whether
this is the case, and the additional factors modulating RAB35
activity remains to be established. Nevertheless, collectively, our
ﬁndings reveal that RAB35 is a key molecular component of an
oscillating, excitable network required to set the steering compass
of chemotactically migrating cells (Fig. 9).
RAB35 has recently been shown to be a potentially oncogenic
RAB protein48. This function was shown to be mediated by the
ability of RAB35 to regulate a p85/PI3K–AKT axis, which, in
turn, impinges onto PDK1 and mTORC2 pathways48. Con-
sistently, two somatic RAB35 mutations found in human tumours
generate alleles that constitutively activate PI3K/AKT signalling,
suppress apoptosis and transform cells in a PI3K-dependent
manner48. Our ﬁnding indicates that RAB35 and the oncogenic-
associated mutant forms are also implicated in CDR formation
and chemotactic migration in a AKT-independent, but PI3K-
dependent fashion. These results argue that certain tumours
might speciﬁcally exploit and select for alterations of RAB35 also
to increase their invasiveness and ability to navigate through
complex interstitial environment. We further showed that RAB35
elevation is sufﬁcient to enhance macropinocytosis. This process
has recently emerged as a major scavenging route for protei-
naceous material and lipid sources in order to reﬁll the amino
acid pools, fuel mitochondrial metabolism and lipid biosynthesis,
particularly in tumours bearing KRAS or PI3K activating muta-
tions23,59, ultimately enabling survival in a nutrient-deprived
tumour microenvironment. Thus, RAB35 might not only be
important for the onset of tumorigenesis, but also to increase
nutritional tumour adaptation and progression, possibly by pro-
moting tumour dissemination potential.
Methods
Plasmids antibodies and reagents. Mouse RAB GTPases siRNA library together
with experimental controls used in the screening were provided by Ambion (see
Supplementary Data 1 for details). Doxycycline-inducible pSLIK-hygromycin
(hygro) lentiviral vector carrying the human RAB35 sequence fused to the HA-tag
was obtained by Gataway Technology (Invitrogen), following the manufacturer’s
protocol. Lentiviral expression construct pRRL-Lifeact-EGFP-puromicin (puro)
was a gift of Olivier Pertz (University of Basel, Basel, Switzerland). Lentiviral
expression constructs Mission shRNA TRC2-pLKO-puro for stable down-
regulation of RAB35 (SHCLNG-NM_198163, TRCN0000100534, Mouse;
SHCLNG-NM_006861, TRCN0000380003, Human) and pLKO.1-puro Non-
Mammalian shRNA Control (SHC002) were purchased from Sigma-Aldrich. GFP-
RAB35 WT, -RAB35 S22N and -RAB35 Q67L expression constructs were kind
gifts from Cécile Gauthier-Rouviere. siRNA oligos targeting human RAB35 (siRNA
IDs: s21707; s21708; s21709) and RAB35 GEFs and Effectors were purchased from
Ambion (siRNA IDs: s105812; s116366; s87812; s103715; s115827; s97565; s95591;
s101197; s233383; s65847). siGENOME SMARTpool targeting mouse RAC1
(19353) was from Dharmacon.
Mouse monoclonal antibodies anti-phospho-ERK1–2 (Thr202/Tyr204, #9106
dilution 1:200), anti-ERK1-2 (#9102, dilution 1:500), rabbit monoclonal antibodies
anti-phospho-AKT (Ser473, #4058, dilution 1:1000), anti-phospho-PDGFRB
(Tyr1009, #3124, dilution 1:500), anti-PDGFRB (#4564, dilution 1:500) and the
rabbit polyclonal antibody anti-AKT (#9272, dilution 1:500) were purchased from
Cell Signaling. The rabbit polyclonal antibody anti-RAB35 (#113292-AP, dilution
1:600) was from ProteinTech. The rabbit polyclonal antibody anti-p85α (#sc-423,
dilution 1:500) was from Santa Cruz Biotechnology and the mouse monoclonal
antibody anti-p85 (#05-212, dilution 1:1000) was from Merck Millipore. The anti-
Mouse CD140b (PDGF Receptor b, dilution 1:200) PE for FACS analysis was from
eBioscience (#12-1402-81). Mouse monoclonal antibodies raised against α-tubulin
Fig. 5 RAB35 is dispensable for chemotaxis when CDR do not form. a Serum-starved MEF were stimulated with PDGF (20 ng/ml) or 10% serum for 10’,
ﬁxed and stained with FITC-Phalloidin to detect F-actin and CDRs. We plotted % cell forming CDRs. Data are the mean ± SD (n= 120 cells/experiments,
three independent ones). b Scrambled (Scrb) and Rab35-silenced (siRab35) MEFs seeded into 8-μm pore Transwell with PDGF (20 ng/ml) or 10% serum
added in the lower chamber. Crystal violet staining was done after 3 h to detect total number of seeded cells, and after 20 h to detect migrated cells to the
lower side. Chemotaxis was quantiﬁed as number of cells/ﬁeld ± SD (>6 ﬁelds of view/condition, in two independent experiments). Data are the mean ±
SD. **p < 0.01. Gene silencing was veriﬁed by qRTPCR. Scale bar, 50 μm. c Serum-starved MEFs were stimulated with PDGF (20 ng/ml) or EGF (100 ng/
ml) for 10′, ﬁxed and stained with FITC-Phalloidin to detect F-actin and CDRs. Red arrows indicate CDRs. CDR score was calculated by normalizing the
number of CDR-positive cells per each condition against the PDGF-stimulated sample, used as control. Data are the mean ± SD (n > 100 cells/condition in
two independent experiments). Scale Bar, 20 μm. d Scrambled (CTR) and Rab35-silenced (Rab35 KD) MEFs were seeded into 8-μm pore Transwell. PDGF
(20 ng/ml) or EGF (100 ng/ml) was added to the lower chamber. Cells migrated through the transwell were stained counted as described in b. Scale bar,
40 μm. The extent of chemotaxis was quantiﬁed as the average number of cells/ﬁeld ± SD (>10 ﬁelds of view/condition, in two independent experiments).
Data are the mean ± SD, **p < 0.01. RAB35 downregulation was assessed by immunoblotting. Vinculin is a loading control. e Conﬂuent scrambled (Scrb)
and Rab35-silenced (siRab35) MEFs were scratched with a pipette tip and recorded by time-lapse. Still images at the indicated time point are shown
(Supplementary Movie 9). The percentage of free area covered was determined with ImageJ tool. A representative experiment out of four is shown. Gene
silencing was veriﬁed by qRTPCR. Scale Bar, 100 μm
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(#T5168) or Vinculin (#V9131) and the rabbit polyclonal anti-GFP antibody
(#SAB4301138) were from Sigma-Aldrich and they were all used at 1:500 dilution.
Mouse monoclonal anti-HA was homemade and derived from HA hybridoma HA-
1951. Secondary antibodies conjugated to horseradish peroxidase were from Cell
Signaling (#7074, #7076, dilution 1:5000). Cy3-secondary antibodies from Jackson
ImmunoResearch (#711-165-152, #715-165-150, dilution 1:400), Dapi (#D-1306)
and AlexaFluor 488 (#A-11055, #A-21202) were from Thermo Fisher Scientiﬁc.
FITC-conjugated Phalloidin (#P5282), LY294002 (#L9908), Doxycycline Hyclate
(#D9891) and Fibronectin (#F1056) were from Sigma-Aldrich. The MK-2206
(#11593) and GDC-0941 (#11600) were from Cayman Chemical. Dextran,
Tetramethylrhodamine, 70,000 MW (#D1818) used in the macropinocytosis assay
and CellMask Deep Red Plasma membrane Stain (#C10046) were purchased from
Thermo Fisher Scientiﬁc. Human Recombinant PDGF-BB (#GRF-10694) was from
Immunological Sciences; Human Recombinant HGF (#CYT-244) from Prospec;
Human Recombinant EGF (#BPS-90201-3) from Vinci-Biochem; Human Insulin
(#11376497001) from Roche; Hydrocortisone (#H0888-1G) from Sigma-Aldrich.
Lipofectamine RNAiMAX (#13778030) and Lipofectamin 2000 (#11668019) were
from Thermo Fisher Scientiﬁc.
Cell cultures and stable cell lines generation. MEFs were generated from wild-
type C57BL/6J embryos at mid gestation and immortalized through passaging60;
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HeLa and DU145 prostate cancer cells were from ATCC. Cells were maintained in
DMEM high glucose medium (Lonza) supplemented with foetal bovine serum
(10%) and 2 mM L-glutamine. Double p85 alpha and beta KO MEFs were from Dr.
Saskia Brachmann. MEFs were derived from embryos of p85α−/− and p85β−/−
and wild-type mice (129XC57BL/6). The generation of p85α−/− double KO mice
and the establishment of the embryonic ﬁbroblasts from crosses with p85α−/+,
p85β−/− mice has been performed previously and described in details in ref. 61. In
brief, the embryos were transferred onto gelatinized tissue culture dishes and the
MEFs were immortalized after few passages using SV40 large T antigene expressed
as a retroviral vector47. The genotypes of the cells were determined by PCR. MEFs
p85α−/−p85β−/− were reconstituted by expressing a p85α construct61. MCF10.
DCIS.com cells were kindly provided by Dr. John F. Marshall (Barts Cancer
Institute, Queen Mary University of London) and maintained in DMEM/F12
medium (Invitrogen) supplemented with 5% horse serum, 0.5 mg/ml hydro-
cortisone, 10 μg/ml insulin and 20 ng/ml EGF. PC3 prostate cancer cells were
cultivated in Ham’s F12 with foetal bovine serum (10%).
All cell lines have been authenticated by cell ﬁngerprinting and tested for
mycoplasma contamination. Cells were grown at 37 °C in humidiﬁed atmosphere
with 5% CO2. MEF cells were infected with pSLIK-hygro-HA-RAB35, pRRL-
Lifeact-EGFP-puromycin and TRC2-pLKO-puro shRAB35 lentiviruses and
selected with the appropriate antibiotic (Hygromycin-B 300 μg/ml and Puromycin
2 μg/ml) to obtain stable and inducible cell lines. MCF10.DCIS.com cells were
infected with TRC2-pLKO-puro shRAB35 and shCtrl lentiviruses and selected with
Puromycin 2 µg/ml to obtain control and RAB35 stably silenced cells. Packaging of
lentiviruses was performed following standard protocols. Four batches of viral
supernatant were collected and ﬁltered through 0.45 μm ﬁlters. Cells were subjected
to four cycles of infection. RAB35 ectopic expression in MEF pSLIK-HA-RAB35
cells was induced by Doxycycline Hyclate (2.5 μg/ml).
Production of ready-to-transfect 96-wells plates. The siRNA transfection
solution was prepared as in ref. 62. Brieﬂy, into each well of a 96-wells plate, 5 μl of
siRNA stock solutions, with a concentration of 3 μM, were added to 7 μl of
transfection reagent solution (3 μl of OptiMEM containing 0.4 M sucrose+ 1.75 μl
of H2O+ 1.75 μl Lipofectamine 2000) and mixed thoroughly. After 20 min of
incubation at RT, 7 μl of 0.2% gelatin solution were added to each well and the
resulting transfection mixes diluted 1:50 with water (1+ 49 μl, respectively). The
siRNA transfection solution (50 μl) was distributed into empty glass-bottom 96-
wells imaging plates (Greiner, Item-No. 655891). In total, 10 replicates for each
plate layout were produced and immediately dried in a multi-wells Speed Vac for
2.5 h at medium drying force. “Ready to transfect” 96-wells plates were stored in
plastic boxes containing drying pearls orange (Fluka) until usage.
Primary screening for identifying CDR-related RABs. MEF cells were seeded
into the “ready to transfect” 96-wells imaging plates (800 cells/well) using the cell
seeding device Multidrop Combi (Thermo Scientiﬁc). After 48 h of incubation at
37 °C and 5% CO2, cells were serum starved for 2 h, stimulated with PDGF (20 ng/
ml) for 10 min and ﬁxed in 4% paraformaldehyde (PFA). Fixed samples were
permeabilized with 1× phosphate-buffered saline (PBS)+ 0.1% Triton X-100+ 1%
bovine serum albumin (BSA) for 20 min, followed by FITC-Phalloidin staining (3
μg/ml, for 1 h), Dapi staining (0.5 ng/ml, for 10 min) and CellMask Deep Red
staining (1:5000, for 10 min).
Images were acquired with an automated epiﬂuorescence microscope (IX-81;
Olympus-Europe) equipped with a stabilized light source (MT20, Olympus-
Biosystems, Munich), a ﬁrewire camera (DB-H1, 1300 × 1024, Olympus-
Biosystems), an objective (Plan10x, NA 0.4; Olympus-Europe) and ﬁlter sets from
ChromaInc. An image-based autofocusing routine was used to focus on the
maximum number of interphase cells (scoring size, intensity, contrast) in a ﬁeld of
view (Dapi channel). Images of nine sub-positions per well were acquired at three
wave-lengths in order to image Phalloidin, CellMask and Dapi stainings with
exposure time of 500, 50 and 5 ms respectively.
Typically, upon 48 h of interference, MEFs were serum starved for 2 h followed
by stimulation with PDGF. Samples were subsequently processed for
immunoﬂuorescence analysis using FITC-Phalloidin to visualize the actin-rich
structures of interest, CellMask Deep Red staining, a membrane dye suitable for
automated cell segmentation, and Dapi to obtain information about nuclear
morphology and cell density. Images were automatically acquired and analysed by
a dedicated-image analysis pipeline to quantitatively assess CDRs formation across
the different experimental conditions and generate a list of putative candidate
genes regulating these structures (Fig. S1A). To evaluate the reliability of the
primary screening, experimental controls characterized during the assay
optimization phase were distributed on the pre-coated 96-well plates. More
speciﬁcally, we included: siRNAs targeting Plk1 and Incenp, two genes involved in
mitotic segregation, the knock down of which results in obvious morphologically
altered nuclei, as transfection efﬁciency controls; scrambled sequences targeting no
endogenous genes in the mouse genome and thus not affecting CDR formation
(siEGFP), and Pdgfrb silencing oligos, which abrogate CDRs, as negative and
positive controls, respectively. We carried out at least three biological replicates for
each plate layout acquiring nine ﬁeld of view for each well and three different
ﬂuorescent channels (GFP, Cy5 and Dapi) per position.
Image and data analysis of the primary screen. The image and data analysis was
performed using the open-source software packages ilastik63, CellProﬁler64 and R
(https://www.r-project.org/). To analyse Phalloidin images and distinguish between
pixels that belong to CDRs from other actin-rich structures such as stress ﬁbres, we
trained a pixel-based classiﬁer in the supervised pixel classiﬁcation software ilastik.
We manually labelled pixels in 23 representative images from our screen, covering
different treatments and intensity levels. We trained two classes of pixels, namely
CDR pixels and Background pixels, where the latter also included non-CDR actin
staining, such as stress ﬁbres. We saved the resulting classiﬁer ﬁle to disk and used
it in CellProﬁler’s ClassifyPixels module (see below). The image analysis was
performed using CellProﬁler. We describe the main steps of the CellProﬁler
pipeline; for more details please download the full pipeline, which runs with ver-
sion 2.0.11710 of CellProﬁler (http://cellproﬁler.org/previous_releases/). We seg-
mented nuclei in the Dapi image by means of an automated threshold
(IdentifyPrimaryObjects module with the RobustBackgroundGlobal thresholding
method). We used the MeasureImageQuality module to measure the focus quality
of the Dapi image (ImageQuality_PowerLogLogSlope_nucleus); this value was used
in our downstream analysis in R (see below) to reject out-of-focus images. Using
the segmented nuclei as seeds, we applied a watershed algorithm on a smoothed
and background corrected CellMask image in order to segment the cells (Identi-
fySecondaryObjects module with the Watershed-Image method). We shrank the
cell objects by 5 pixels in order to avoid cell boundaries, because they were often
misclassiﬁed as CDRs in the Phalloidin image. Using the FilterObjects module we
rejected cells that were of very small size (less than 2500 pixels), had too dim
Phalloidin staining (less than 200 mean value; the maximum being 4095 for our 12
bit data) and had too many Phalloidin pixels (more than 500) that were saturated
(grey value= 4095). Our starting point for the segmentation of CDRs was a
probability image generated by CellProﬁler’s ClassifyPixels module. The Classify-
Pixels module applies the ilastik classiﬁer (see above) on the Phalloidin image and
outputs a new image with intensity values between zero and one. The closer the
value is to one, the more certain the classiﬁer is that the respective pixels belongs to
a CDR. We applied a threshold of 0.51 to the probability image in order to obtain a
binary image. (Note: As long as the binary image represents CDR pixels, the exact
threshold value is not critical. For example, lowering the threshold slightly would
slightly increase the number of CDR pixels in all images; as our ﬁnal score of the
screen is computed relative to the negative control siRNA (siEGFP) this increase
would cancel out.) To distinguish CDRs from noise we performed a morphological
Fig. 6 RAB35 is required for 1D migration and chemoinvasion in 3D. a Still images of control (shCtrl) and Rab35-silenced (shRab35) MEFs migrating on 10-
µm wide ﬁbronectin-coated lines (Supplementary Movie 11). Scale bar, 100 µm. Velocity, effective length and change of direction frequency are
automatically calculated and shown as whiskers box plots. Solid horizontal line=median value; box outlines= 25th–75th percentiles of SD; whiskers=min
and max values. ****p < 0.0001; ***p < 0.001. b Migration toward HGF of control (shRNA Ctrl) and Rab35-silenced (shRNA Rab35) MCF10.DCIS.com cells
in transwell assays as shown in Fig. 4a. The migration index was calculated by normalizing the number of cells/ﬁeld with respect to control (without
gradient). Data are the mean ± SD (>6 ﬁelds of view/condition). Gene silencing was veriﬁed by qRTPCR. **p < 0.01. c The chemoinvasive ability toward
HGF (100 ng/ml) of control and Rab35-depleted MCF10.DCIS.com cells assessed in Matrigel-coated Transwell invasion assays. Cells migrated through the
Matrigel layer were stained with crystal violet and invasion index was calculated as in b. Data are mean ± SD (>6 ﬁelds of view/condition, in three
independent experiments). **p < 0.01. d Control and Rab35-silenced MCF10.DCIS.com cells were placed on one side of a chamber slide in which 2.3 mg/ml
of acid extracted-only type I collagen gel containing 100 ng/ml HGF and 100 ng/ml EGF was polymerized. Left: still phase contrast images from time-lapse
sequence (Supplementary Movie 12). Invading cells are indicated by white arrows. Scale bar, 100 µm. Right: Migration tracks of invading cells over 48 h.
Quantiﬁcation of cell invasion is the mean forward invasion index ± SEM and mean velocity ± SEM (>30 cells/experimental condition, three independent
invasion assays). ****p < 0.0001; ***p < 0.001. e Control and Rab35-silenced MCF10.DCIS.com cells were grown on a thick Matrigel/type I collagen mixture
and overlaid with 2% Matrigel-containing media. After the formation of 3D spheroids, cells were cultured in the presence (+) or absence (−) of HGF for
48 h. Magniﬁcation of the boxed area shown on the right. The percentage of 3D structures with invasive outgrowths was quantiﬁed and expressed as
mean ± SD (n= 60 spheroids/condition, two independent experiments). Scale bar, 400 µm. p-values are from paired Student’s t-test
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closing operation with a diameter of 7 pixels to connect neighbouring CDR pixels
and then rejected all connected components (CDR objects) with an area of less
than 25 pixels. For all cells—that were kept according to our ﬁltering criteria
described above—we computed the number of CDR-positive pixels and then
computed the average value of all cells in the image as the ﬁnal readout
(“CDR_PerImage_RawScore”).
The ﬁnal output of our CellProﬁler analysis was one table (Supplementary
Data 2) where each row contained information about one image set. This
“per-image” table was further analysed using R. First, we performed a
per-image quality control by rejecting out-of-focus images
(ImageQuality_PowerLogLogSlope_nucleus <−2) and by rejecting images with
very few cells (Count_Cells <20). Then we performed a per-plate batch correction
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of the CDR_PerImage_RawScore (see above). For each plate, we divided the
CDR_PerImage_RawScore of all images by the average CDR_PerImage_RawScore
of all images that were treated with our negative control siRNA (siEGFP), yielding
the CDR_PerImage_RatioScore. Finally, for each siRNA we computed the mean
value of the CDR_PerImage_RatioScore for all images where the respective
treatment was applied, yielding the ﬁnal CDR-Score, which is given in the table
(Supplementary Data 2).
RNA interference experiments in six-wells format. Cells were reverse trans-
fected by mixing 10 nM of speciﬁc siRNAs with 500 μl of Optimem and 5 μl of
Lipofectamine RNAiMAX Transfection Reagent. For each experiment, scrambled
siRNAs were used at the same concentration as speciﬁc siRNAs. Silencing efﬁ-
ciency was controlled by qRTPCR.
Quantitative RTPCR analysis. Total RNA was extracted using RNeasy Mini kit
(Qiagen). SuperScript VILO cDNA Synthesis kit from Invitrogen was used for
reverse transcribe 1 μg of total RNA.
Gene expression was analysed as in ref. 65. Sequence-speciﬁc primers and
probes were selected from the Assay-on-Demand products (TaqMan® gene
expression assay; Applied Biosystems). Primer assay IDs were:
GAPDH, Hs99999905_m1 and Mm99999915_g1; RAB35, Hs00199284_m1 and
Mm01204416_m1; PDGFRB, Mm00435546_m1; RAB8a, Mm00445684_m1;
RAB8b, Mm00557812_m1; RAB5a, mm01278246_m1; RAB5b, mm00834147_g1;
RAB5c, mm00659190_m1; RAC1, mm01201653_mh; DENND1a,
Mm00620186_m1; DENND1b, Mm01285090_m1; DENND1c, Mm01227405_m1;
DENND6b, Mm01308059_m1; FLCN, Mm00840973_m1; OCRL,
Mm00623482_m1; RUSC2, Mm01349595_m1; ACAP2, Mm01342334_m1;
MICAL1, Mm00506780_m1; MICALL1, Mm01300206_m1; FSCN,
mm00456046_m1.
Western blotting. Cells were lysed in RIPA buffer containing proteases and
phosphatases inhibitors. Total cell lysates were resolved by gel SDS-PAGE, trans-
ferred onto Protran Nitrocellulose Transfer membrane (Whatman), probed with
the appropriate antibodies and visualized with ECL Plus western blotting detection
reagents (GE Healthcare). Membranes were blocked for 1 h in TBS/0.1% Tween/5%
BSA for antibodies recognizing phosphorylated proteins or in TBS/0.1% Tween/5%
milk for antibodies recognizing the total proteins. Primary antibodies incubation
was performed according to the manufacturer’s instructions. Secondary antibodies
were diluted 1:10,000 and incubated for 1 h at RT.
Uncropped gels of all immunoblots are included in Supplementary Figures 5–8.
Immunoﬂuorescence. Cell ﬁxation was performed in 4% PFA and permeabiliza-
tion in 0.1% Triton X-100 and 1% BSA for 10 min. After 1× PBS wash, samples
were incubated with primary antibodies for 1 h at room temperature. Coverslips
were washed in 1× PBS before the secondary antibody incubation for 1 h at room
temperature, protected from light. FITC-Phalloidin was added in the secondary
antibody step, where applicable. After 1× PBS washing step, nuclei were stained
with 0.5 ng/ml Dapi and the plasma membrane was marked with CellMask Deep
Red staining where indicated. Samples were mounted on glass slides in anti-fade
mounting medium (Mowiol). Antibodies were diluted in 1× PBS and 1% BSA.
Images were acquired by a wide-ﬁeld ﬂuorescence microscope or a confocal
microscope.
CDR formation assay. To evaluate the formation of CDRs, MEF cells were serum
starved for 2 h, stimulated with PDGF (20 ng/ml) for 10 min and ﬁxed in 4% PFA
for 10 min. After FITC-Phalloidin staining, the number of CDR-positive cells was
counted and normalized to an internal control in order to generate the CDR score.
The experimental procedure in HeLa cells was slightly different: cells were seeded
on 0.5% Matrigel-coated coverslips, serum starved overnight and stimulated with
HGF (100 ng/ml) for 10 min. At least 200 cells per experimental condition were
analysed. Data are the mean of at least three independent experiments.
Live monitoring of CDRs and analysis of cell protrusions. Cells were seeded in
six-wells plate (2 × 104 cells/well) and cultivated in complete medium for 48 h.
Where indicated, doxycycline 2.5 mg/ml was added 16 h before the experiment in
order to induce RAB35 expression. Medium was refreshed before starting the time-
lapse microscopy session. An Olympus ScanR inverted microscope with ×20
objective was used to take phase contrast and ﬂuorescence images every 30″ over a
1 h period, otherwise differently indicated. The assay was performed using an
environmental microscope incubator set to 37 °C and 5% CO2 perfusion. Dox-
ycycline was maintained in the media for the total duration of the time-lapse
experiment. The number of CDRs per cell, formed during the live imaging session,
was counted and reported in dot plot graphs. Each assay was done three times and
at least 25 cells/condition were counted in each experiment. Where indicated,
LY294002 (20 μM) was added 2 h before imaging. To capture the dynamics of
protrusion formation in PDGF-treated or RAB35-ectopically expressing cells,
movies generated by time-lapse microscopy were analysed by the Multiple
Kymograph plugin of ImageJ software.
Dextran internalization assay. Cells were plated on un-coated glass coverslips
and cultured in complete medium for 24 h. MEF shCtrl and shRAB35 cells were
serum starved for 2 h and incubated concomitantly with 1 mg/ml TMR-dextran
(70,000 MW) and PDGF (20 ng/ml) for 1 h at 37 °C. After four washing steps in
ice-cold PBS, samples were ﬁxed in PFA 4% and stained with Dapi. In the case of
MEF pSLIK-HA-RAB35 cells, doxycycline was added to the media 16 h before
performing the experiment and TMR-dextran (70,000MW) was incubated for 1 h
at 37 °C before cell ﬁxation. Images were acquired by a wide-ﬁeld ﬂuorescence
microscope. The dextran uptake was quantiﬁed by measuring the mean value of the
corrected total cell ﬂuorescence per cell in all the different experimental conditions.
CTCF= integrated density – (area of selected cell × mean ﬂuorescence of back-
ground readings). Three biological replicates were performed and at least 40 cells/
condition were counted in each experiment.
Boyden chamber and Matrigel invasion assay. Cells were seeded into the upper
compartment of a transwell or a Matrigel invasion chamber with 8 μm pore size
ﬁlters (Corning) and the chemoattractant (PDGF 20 ng/ml, HGF 100 ng/ml, FBS
10% or EGF 100 ng/ml) was added to the lower chamber. After 20 h of incubation
at 37 °C, samples were ﬁxed in 4% PFA and cells migrated to the lower side of the
microporous membrane were Crystal violet stained. Cells on the top of the
membrane were scraped away. The average number of migrating cells per each
experimental condition was counted and reported.
Random migration assay. The capability of cells in moving in the absence of any
chemotactic stimulus was monitored by time-lapse phase contrast microscopy.
Cells were seeded sparsely in a six-wells plate (1 × 104 cells/well) in complete media
and where indicated, supplemented with doxycycline (2.5 μg/ml) 16 h before
starting the experiment. Random cell motility was monitored over a 24 h period.
Pictures were acquired every 5 min from 6 positions/condition, using a motorized
Olympus Scan^R inverted microscope with ×4 objective. All the experiments were
performed using an environmental microscope incubator set to 37 °C and 5% CO2
perfusion. Single cells were manually tracked using Manual Tracking Tool ImageJ
software plugin. Migration plot and relative parameters were obtained by Che-
motaxis Tool from Ibidi.
Chemotaxis assay. The ability of cells in responding to a chemotactic stimulus
was tested by time-lapse phase contrast microscopy using ﬁbronectin-coated 2D
chemotaxis μ-slides from Ibidi. 2 × 10 3 cells were loaded into the central
transversal channel and incubated at 37 °C for 30 min in order to allow the
adhesion to the substrate. A PDGF-BB gradient (0–20 ng/ml) was generated
according to the manufacturer’s instructions. Cell motion was recorded using a
motorized Olympus Scan^R inverted microscope with ×10 objective for a 24 h
period, taking pictures every 5 min. All the assays were performed using an
environmental microscope incubator set to 37 °C and 5% CO2 perfusion. Che-
motactic tracks were obtained using the Manual tracking ImageJ software plugin
Fig. 7 Molecules acting in concert with RAB35 to promote Dorsal Rufﬂes formation. a Schematic representation of the signalling pathway leading to CDR
formation. b RAB5 and RAC are required for RAB35-dependent CDR formation but PDGFRB is dispensable. pSLIK-HA-RAB35-human-MEFs were silenced
for Pdgfrb, or Rab5 or Rac1 and treated or not with doxycycline to induce the transgene expression. CDR formation was monitored by time-lapse phase
contrast microscopy. Still phase contrast images from time-lapse sequence (Supplementary Movie 13) are shown. Red arrows indicate CDRs. Scale bar,
100 µm. The number of CDRs/cell/h was reported as mean ± SEM (>30 cells/condition, three independent experiments). ****p < 0.0001; ns not
signiﬁcant, paired Student’s t-test. The silencing of genes was veriﬁed by qRTPCR. c Silencing of Rab35 GEFs or effectors. MEF cells were interfered for the
indicated Rab35 GEFs or effectors and tested for their ability in forming CDRs upon PDGF stimulation. Representative Phalloidin-stained images are
reported for each experimental condition. Scale bar, 50 µm. CDRs were manually counted and normalized against the scrambled sample. Data are the
mean ± SD (n > 200 cells/condition in three independent experiments). ****p < 0.0001; **p < 0.01, paired Student’s t-test. The silencing of the targeted
genes was veriﬁed by qRTPCR. In the case of p85, double p85α and β KO MEFs47 were employed and the loss of p85 isoforms was conﬁrmed by western
blotting. In the latter case, as control we used both p85α+/−p85β−/−MEFs (p85−/+, derived from sibling mice) as well as p85α−/−p85β−/−MEF in
which p85α was re-expressed
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and the chemotaxis plots and migratory parameters were obtained with the
Chemotaxis Tool from Ibidi.
Cell migration through an array of pillars. Τhe array of pillars was fabricated
with two-photon polymerization on glass substrates. The structure consisted of two
components: a dense micropillar array and wall-like barriers. The structure
components were ﬁrst designed using CAD software (Autodesk Inventor, Auto-
desk). The inter-pillar distance was set to 4 μm in order to ensure the mechanical
constriction of the cells during their migration through the array and the pillar
thickness was set to 3 μm in order to provide the necessary mechanical stability to
the structure. The barriers aimed to prevent cells from migrating around the pillar
array (instead of migrating through it) or cells that would leave the array by
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moving in transverse direction. The structural elements of the pillars and barriers
(mesh slicing and hatching) and printing parameters of the whole structure (laser
power, scan speed) were designed with the programme DeScribe v.2.4.4 (Nano-
scribe GmbH), which creates a ﬁle readable by the laser lithography system. The
sample fabrication was completed with a 3D laser lithography system (Photonic
Professional GT, Nanoscribe GmbH, Germany) used in conventional oil-
immersion mode. This involved passing a two-photon laser (780 nm laser, laser
power 12.5 mW, scan speed 800 μm/s) from a ×63 objective lens through a layer of
oil beneath the glass substrate, polymerizing the photoresist on the top side of the
glass substrate. The photoresist chosen was a biocompatible66, organic–inorganic
hybrid polymer (Ormocomp®, MicroResist Technology GmbH). The resist was
drop-casted on the glass substrates and pre-baked at 80 °C for 2 min. After laser
writing, the resist was baked at 130 °C for 10 min, developed in OrmoDev®
developer (MicroResist Technology GmbH) for 10 min to remove the un-
polymerized resist and rinsed in isopropanol (IPA) followed by drying in a critical
point dryer (Automegasamdri R 915B, Tousimis).
The device used to create a chemotactic gradient was a commercially available
microﬂuidic chamber (sticky-Slide Chemotaxis, Ibidi) which enables the creation of
a stable, linear gradient for more than 24 h. The glass substrate with the
microstructures printed on top was attached on the self-adhesive underside of the
chamber, with the micropillar array placed in the middle area. The chamber was
ﬁlled with 70% ethanol for 1 h for sterilization, washed three times with 1× PBS for
5 min and incubated with ﬁbronectin (10 μg/ml) for 1 h at 37 °C. Afterwards,
ﬁbronectin was gradually replaced by 1× PBS and ﬁnally by cell medium. 104 cells
were seeded from the inlets of the cell pool area (Fig. 4d) and were gently
distributed over the cell pool area, with attention that they do not ﬂoat over the
pillars. The chambers were incubated 2 h at 37 °C and once the cells were spread,
the chemoattractant (PDGF-BB) was added on the cell exit area at a concentration
of 20 ng/ml. Cell motion was recorded using a motorized Olympus Scan^R
inverted microscope with 10 × objective for a 24 h period, taking pictures every 10
min. All the assays were performed using an environmental microscope incubator
set to 37 °C and 5% CO2 perfusion.
1D migration on micropatterns. Micropatterns of ﬁbronectin-coated lines (10 μm
of width) were fabricated using photolithography as previously described67. Brieﬂy,
the glass surface was ﬁrst activated with plasma (Plasma Cleaner, Harrick Plasma)
and then coated with cell repellent PLL-g-PEG (Surface Solutions GmbH, 0.5 mg/
ml in 10 mM HEPES pH 7.3). After washing with PBS and deionized water, the
surface was illuminated with deep UV light (UVO Cleaner, Jelight) through a
chromium photomask (JD-Photodata). Finally, coverslips were incubated with
ﬁbronectin (Sigma, 25 μg/ml in 100 mM NaHCO3 pH 8.4). Cells were detached
using EDTA 0.02% (Versane; GIbco) and left to attach on micropatterns. After-
wards, the coverslips were mounted in 35 mm magnetic chambers (Chamlide) for
imaging. Cell locomotion was monitored by using a motorized Olympus Scan^R
inverted microscope with ×10 objective for a 10 h period, acquiring images every 5
min. All the experiments were performed using an environmental microscope
incubator set to 37 °C and 5% CO2 perfusion.
Preparation of ﬁbronectin-coated suspended ﬁbres. Arrays of ﬁbronectin-
coated suspended ﬁbres were prepared as previously described68.
Collagen invasion assay. Type I collagen, at the ﬁnal concentration of 2.3 mg/ml,
was diluted in DMEM, Hepes (50 mM), NaOH (5 mM) and NaHCO3 (0.12%) in
the presence of HGF and EGF (100 ng/ml) and polymerized in homemade
migration chambers (0.4-mm-thick) at 37 °C for 1 h. Cells were seeded on the top
of the collagen matrix and the chambers were sealed with dental glue and incubated
at 37 °C, 5% CO2. Cell locomotion through the 3D geometrically deﬁned envir-
onment was followed by time-lapse phase contrast microscopy using a Nikon
Eclipse TE2000-E microscope equipped with an incubation chamber for tem-
perature and CO2 control. Images were acquired every 10 min for a 48 h period.
Cell trajectories were manually tracked using Manual Tracking Tool ImageJ soft-
ware plugin. Invasive parameters were extrapolated by Chemotaxis Tool from Ibidi.
MCF10.DCIS.com cells 3D invasion assay. Acini were grown in 3D basement
membrane cultures according to the standard protocol69. Brieﬂy, Nunc Lab-Tek II
8-wells chamber slides were coated with a mix of collagen/Matrigel and allowed to
solidify for 1 h at RT. Single cells were seeded in growing media supplemented with
2% of Matrigel and 5 ng/ml of EGF (2.5 × 103 cells/well). Four days after seeding,
the formation of invasive outgrowth was triggered by adding HGF (100 ng/ml) to
the media. Phase contrast images were collected before and after growth factor
stimulation. The percentage of 3D acini having invasive outgrowth was calculated.
At least 60 spheroids per experimental condition were analysed.
Flow cytometric analysis. Cell surface levels of PDGF Receptor B were analysed
by ﬂow cytometry as follow. Brieﬂy, 5 × 105 cells were blocked in 1× PBS+ 1% BSA
for 30 min at 4 °C, incubated with the anti-Mouse CD140b (PDGF Receptor b) PE
for 30 min at 4 °C and ﬁxed with 4% PFA for 15 min on ice. Data were acquired
with the FACSCanto (Becton Dickinson) ﬂow cytometer and analysed with FlowJo
version 4.6.2 (Treestar).
Automated immunohistochemistry with Leica BOND-MAX. Immunohisto-
chemical staining was performed as follows: 3-μm-thick sections were prepared
from formalin-ﬁxed parafﬁn-embedded TMA tissue blocks and dried in a 37 °C
oven overnight. The sections were placed in a Bond Max Automated Immuno-
histochemistry Vision Biosystem (Leica Microsystems GmbH, Wetzlar, Germany)
according to the following protocol. First, tissues were deparafﬁnized and pre-
treated with the Epitope Retrieval Solution 2 (pH9) at 100 °C for 20 min. After
washing steps, peroxidase blocking was carried out for 10 min using the Bond
Polymer Reﬁne Detection Kit DC9800 (Leica Microsystems GmbH). Tissues were
again washed and then incubated for 30 min with the primary antibody diluted
(1:50 anti-Rab35, Abcam ab 152138) in Bond Primary Antibody Diluent (AR9352).
Subsequently, tissues were incubated with post primary and polymer for a total of
16 min and developed with DAB-Chromogen for 10 min and counterstained with
haematoxilin for 5 min.
Human samples were collected with inform consent between 1995 and 2010,
unfortunately, without recording their clinico-pathological features, thus impeding
the analysis of RAB35 expression levels with relevant tumour properties.
Statistical analysis. Student’s unpaired t-test was used for determining the sta-
tistical signiﬁcance. Signiﬁcance was deﬁned as ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001
and ∗∗∗∗p < 0.0001. Statistic calculations were performed with GraphPad Prism
Software. Data are expressed as mean ± SEM, unless otherwise indicated.
Data Availability. The authors declare that all data supporting the ﬁndings of this
study are available within the article and its Supplementary Information ﬁles or
from the corresponding author upon reasonable request.
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Fig. 8 A RAB35/PI3K axis is necessary for triggering CDR formation. a PI3K inhibition impairs RAB35-induced CDR formation. pSLIK-HA-RAB35-human-
MEFs were treated or not with doxycycline to induce the transgene expression and incubated with vehicle or LY294002. Still, phase contrast images from
time-lapse sequence (Supplementary Movie 14) are shown. Red arrows indicate CDRs. Scale bar, 50 µm. The number of CDR/cell is the mean ± SEM (n >
30 cells/condition, three independent experiments). ****p < 0.0001. RAB35 expression was veriﬁed by IF. b Genetic ablation of the regulatory subunits of
PI3K abrogates the RAB35-dependent CDR formation. Control or p85α−/− pβ−/− double KO MEFs (p85−/−)47 were infected with pSLIK-HA-RAB35 to
express RAB35 in a doxycycline-inducible fashion imaged by time-lapse phase contrast microscopy. Left: Still phase contrast images from time-lapse
sequence (Supplementary Movie 15). Red arrows indicate CDRs. Scale bar, 50 µm. Middle graph: The number of CDR/cell is the mean ± SEM (n= 50
cells/condition, two independent experiments). ****p < 0.0001; *p < 0.05. Right graph: RAB35 expression was veriﬁed by qRTPCR. Data are the fold
increase of RAB35 mRNA levels of doxycycline-treated with respect to untreated ones. c, d RAB35 regulates AKT activity. c Serum-starved control (shCtrl)
and Rab35-silenced (shRab35) cells were stimulated or not for 10′ with PDGF. Cell lysates were analysed by immunoblotting to detect the indicated total or
phosphorylated proteins. Vinculin is a loading control. d Lysates from pSLIK-HA-RAB35-human-MEFs treated or not with doxycycline were immunoblotted
as in c. e RAB35 co-immunoprecipitates with endogenous p85α. Serum-starved p85α−/− pβ−/− double KO cells (p85−/−) and control MEFs were
stimulated or not for 10’ with PDGF. Cell lysates (1 mg) were immunoprecipitated with anti-p85α monoclonal antibody or irrelevant immunoglobulin G
(IgG). Cell lysates (50 μg) and immunoprecipitates (IPs) were immunoblotted with the indicated antibodies. f Active RAB35 interacts with p85α. Serum-
starved HeLa cells transfected with RAB35 WT, or RAB35 S22N or RAB35Q67L fused to EGFP were mock treated (−) or stimulated with HGF (+) for 10′.
Cell lysates (1 mg) were immunoprecipitated with anti-p85α antibody or irrelevant immunoglobulin G (IgG). Lysates (50 μg) and immunoprecipitates (IPs)
were immunoblotted with the indicated antibodies. p-values are from paired Student’s t-test
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